MedTech Dive September 21, 2023
Susan Kelly

The new funding will also support product innovation efforts as the company builds a position in the fast-growing robotic surgery market.

UPDATE: Sept. 21, 2023: CMR Surgical has its eye on the U.S. market opportunity. “The US markets offer significant market potential for CMR. We are invested in the FDA process and have been judiciously working with the FDA towards submission,” company spokesperson Ashley Davis-Marin told MedTech Dive Thursday in an email.

Dive Brief:

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Medical Devices, Robotics/RPA, Technology, Trends
UN warns of military brain control
Only 20% of AI devices for children used pediatric data to train: 3 notes
Medtech firms have cut thousands of jobs this year. Will layoffs continue in 2025?
Proton therapy market in the US projected to reach $2.67 billion by 2033
How Trump’s second term will affect the medtech industry

Share This Article